Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This is only the draft report amarin can respond up to 9/12 and then presents it on 9/26 maybe reason no pr at this point
A friend of mine who is high up in a BP company says we should be very happy with a B+ rating from ICER. He says he has been in meetings with them before and they are very tough And knit pick everything. A B+ rating is very good in his opinion
So what does our close at$18.42 tell you?
Agree100 percent JL deserves a ton of respect
Agree think long term (1 year from now) we will have expanded label and the stock price will reflect that
Patience which anyone who has been in this since 2011 should know
Talked to a buddy of mine who is high up in a big pharma company and asked him what he thinks we get and he said he wouldn’t be shocked if a standard review due To the amount of data that needs to be reviewed.
He went on to say that we get the label, no way it won’t be approved by the fda. He said all this is noise, think long term and we are golden
I fully agree, think we should get PR but won’t be shocked with SR
Not with Durant heading that way. Could be a pretty good start to a making of a great team
Thank you for the reply much appreciated
JL I remember you saying that but in the post I responded to you originally I meant have you tried to reach out to Bhatt to tell him to focus on the changes in the epa/aa ratios as they are the puppet master
It seems you feel these doctors/amarin are overlooking a crucial part of how this drug works and am curious if you in any way have tried to advise Bhatt or amarin of this
I know it sounds far fetched and a reach but you never know.
JL have you ever tried communicating with Bhatt in some form or way?
Ha ha thanks for the laugh
What!!!
I think it was mentioned here before but no I do not, please tell
Good for you, what a jerkoff
I think he meant by market share all time high
Agree makes you wonder. I am only going off what I have read on this board but wouldn’t be surprised at all if vascepa helps with Alzheimer’s and per a friend of mine who is in the pharma industry he says that would be like finding the holy grail
My opinion GIO gives us the real value. Can only imagine what this company could be worth someday. Biogen today and their Alzheimer’s issue? The CV indication alone is enormous think what an Alzheimer’s indication would mean let alone so many more
What’s taking so long to file the snda? File the freaking thing
I for one am very grateful. Thanks JL and I have to say for all you have done for us I think you deserve more respect then some give you here. I hope you keep posting as you do and ignore some on this board as most love hearing your thoughts
Don’t see any proof this is true so I am taking it that way at this point
Can someone tell me what this means in layman terms. I thought guidelines for 2019 would be posted late 2018 so why is this happening now? Thanks
Funny how we are all in different spots in life. I am 49 and more then comfortable holding out another 5 years for s bigger payout then you guys are hoping and I am in jl’s Camp that selling now may end up leaving a lot of money on the plate so to speak but the word is may as no one can predict the future
Anyways I think we all end up doing very well no matter what the final outcome is
Ok thanks, personally think that is too low but understand your logic
Ok so total deal if cvr hit between $72 and $90 a share?
In terms of you saying BO does that mean you feel that will be accepted by amarin and the shareholders or just an offer?
RAF what do you mean by 80% cvr?
As long as you want. More I understand the better
Sorry Bio not 100% following here. Why is this significant to Amarin and in a good or bad way? Thanks
They own 42.6 million shares so multiply that by current stock price which equals $735 million
Big number no matter how many assets baker brothers has
Can you please share their response when you receive it, thanks
So am I. Bill B always finds a way to slow down high powered offenses. He did it to my bills in super bowl 25 unfortunately and will do it again Sunday
Have to agree but with the government shutdown many things may go unnoticed
Per her response to BB sounds like she has heard the results where really good
Can’t someone send me link to the video please
BB I agree think Amarin worth much more but think of it this way. If a buyout such as I predict your guaranteed $60 with $60 or more to come when certain milestones are hit (which they will). You take some risk off the table.i personally think the true value is going it alone but this scenario doesn’t bother me
I predict something like this:
1 share of Pfizer for every share of Amarin plus $ (maybe $20) plus cvr’s which if all hit add up to $60 more
Total package $120 all said and done
Do you really think that is the plan? If so what could they possibly make an offer for that is fair and what % of shareholders need to agree to the offer for it to be accepted
And if you have cash buy some more which I am today
Great post JL thanks
Just read an article on CNBC regarding some thoughts from warren Buffett on the market. He states an unsettled mind will not make good decisions.
So true. Tough market but IMO if looking long term this is noise